Europe
“AMAG’s category-leading treatments are strong strategic complements to our existing therapeutic portfolio,” said Michael Porter, Covis’ chief executive officer.
AstraZeneca’s Phase III COVID-19 vaccine study in the United States is being further delayed due to the U.S. FDA wanting to take a more thorough look at information related to the trial.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
As part of its half-year 2020 financial report, the company announced significant restructuring that will include cutting 40% of its staff.
Timothy Ray Brown, dubbed the “Berlin Patient,” the first ever to be cured of HIV, died from cancer on September 29.
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business practices.
The German company announced that the new CEO will take the reins in May 2021.
More than one month after the government of Russia announced it approved the world’s first vaccine for COVID-19, it announced it will share preliminary data from the first six weeks of the ongoing Phase III study.
Even when a first vaccine is finally approved, much of the developing world currently stands to be left behind, as it was during the 2009 H1N1 pandemic.
PRESS RELEASES